Literature DB >> 9695458

A fatal overdose of transdermally administered fentanyl.

C Kramer1, M Tawney.   

Abstract

We present a case of fentanyl overdose via mucous membrane absorption. A 31-year-old man presented to the emergency department in respiratory arrest. At intubation, a Duragesic transdermal patch (75 micrograms/h) was recovered from the buccal cavity. A second fentanyl transdermal patch (75 micrograms/h) was noted on the right lateral aspect of the thigh. Postmortem blood evaluation returned a venous fentanyl level of 17.2 micrograms/L. The therapeutic range for analgesic use is 1 microgram/L to 3 micrograms/L. Drug screens were positive for benzodiazepines and cocaine. Mass spectrophotometry/gas chromatography was used to determine fentanyl levels and to confirm drug screen results. Case history, findings at intubation, and high fentanyl blood concentration suggest the cause of respiratory arrest and death was fentanyl overdose.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695458

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  7 in total

1.  Report of a patient chewing fentanyl patches who was titrated onto methadone.

Authors:  Eric Dale; Fleur Ashby; Kalyan Seelam
Journal:  BMJ Case Rep       Date:  2009-11-24

2.  Fatal outcome in a child after ingestion of a transdermal fentanyl patch.

Authors:  Jörg Teske; Jens-Peter Weller; Klaus Larsch; Hans Dieter Tröger; Matthias Karst
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

3.  [Accidental intoxication with unlabeled, generic transdermal fentanyl patches caused by insufficient instruction].

Authors:  S Tank; K Stork; W Skibba; S Zittel; H Andresen; A E Goetz; H Beck
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

Review 4.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 5.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

Review 6.  Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.

Authors:  Craig A Kornick; Juan Santiago-Palma; Natalia Moryl; Richard Payne; Eugenie A M T Obbens
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  Fatal intoxication caused by the application of the multiple transdermals patchs of fentanyl.

Authors:  Issam Serghini; Youssef Qamouss; Mohamed Zoubir; Jaafar Salim Lalaoui; Mohamed Boughalem
Journal:  Pan Afr Med J       Date:  2015-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.